Quantum BioPharma Ltd.
$3.12
▼
-9.75%
2026-04-21 09:01:01
www.quantumbiopharma.com
NCM: QNTM
Explore Quantum BioPharma Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$25.24 M
Current Price
$3.12
52W High / Low
$52 / $2.85
Stock P/E
—
Book Value
$1.81
Dividend Yield
—
ROCE
-300.19%
ROE
-3.47%
Face Value
—
EPS
$-8.2
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
—
Beta
0.29
Debt / Equity
36.77
Current Ratio
1.07
Quick Ratio
1.06
Forward P/E
-0.45
Price / Sales
—
Enterprise Value
$18.24 M
EV / EBITDA
-1.24
EV / Revenue
—
Rating
Strong Buy
Target Price
$12.61
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Alto Neuroscience, Inc. | $27.33 | — | $885.53 M | — | -38.28% | -41.8% | $28.11 / $2.09 | $4.74 |
| 2. | Fate Therapeutics, Inc. | $1.39 | — | $158.12 M | — | -52.22% | -51.84% | $1.94 / $0.91 | $1.8 |
| 3. | Tenaya Therapeutics, Inc. | $0.74 | — | $169.71 M | — | -70.98% | -83.84% | $2.35 / $0.36 | $0.57 |
| 4. | OSR Holdings, Inc. | $0.6 | — | $19.87 M | — | 79.82% | -20.03% | $1.79 / $0.38 | $3.46 |
| 5. | Galmed Pharmaceuticals Ltd. | $0.75 | — | $4.81 M | — | -38.45% | -64.21% | $2.68 / $0.41 | $3.49 |
| 6. | HCW Biologics Inc. | $0.41 | — | $2.94 M | — | -4764.31% | -897.37% | $17.8 / $0.25 | $-0.8 |
| 7. | Maravai LifeSciences Holdings, Inc. | $3.61 | — | $928.01 M | — | -17.71% | -48.59% | $4.11 / $1.67 | $1.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -2.36 M | -4.66 M | -4.91 M | -3.39 M | -6.09 M | — |
| Net Profit | -3.03 M | -5.32 M | -9.25 M | -8.58 M | -5.36 M | — |
| EPS in Rs | -0.52 | -0.91 | -1.59 | -1.47 | -0.92 | -4.37 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -15.32 M | -15.88 M | -19.57 M | -27.43 M |
| Net Profit | -26.18 M | -14.2 M | -17.9 M | -23.61 M |
| EPS in Rs | -4.49 | -2.44 | -3.07 | -4.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 11.16 M | 17.12 M | 17.47 M | 38.41 M |
| Total Liabilities | 6.06 M | 6.68 M | 4.57 M | 7.87 M |
| Equity | 6.92 M | 11.48 M | 13.24 M | 30.54 M |
| Current Assets | 6.48 M | 12.05 M | 11.09 M | 17.85 M |
| Current Liabilities | 6.06 M | 6.68 M | 4.57 M | 7.83 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8.24 M | -6.88 M | -10.83 M | -28.33 M |
| Investing CF | -1.95 M | -1.5 M | -0.27 M | 12.12 M |
| Financing CF | 6.1 M | 11.62 M | -3.13 M | -2.07 M |
| Free CF | -8.24 M | -6.88 M | -10.83 M | -28.7 M |
| Capex | — | — | — | -0.36 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 20.66% | 24.17% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-08-15 | 1:0.0153846 |